There is an urgent need for the discovery of new drugs against infectious diseases and cancer. Globally, infectious diseases are prevalent, with pathogens constantly evolving, leading to a rise in ...

The revised prices will apply to approximately 1,000 drugs listed under the National List of Essential Medicines. Price ...

Essential medicines for managing conditions like diabetes, cancer, heart disease, and bacterial infections such as painkillers, antibiotics, anti-infectives, anti-diabetics and cancer drugs are set to ...

In a major development that could affect the many patients suffering from serious illnesses, prices of crucial drugs used to ...

National Pharmaceutical Pricing Authority has authorized this price hike for approximately 1,000 drugs listed in the NLEM.

Beginning April 1, prices for essential drugs like painkillers, antibiotics, and anti-diabetic medicines will rise by 1.74%.

(Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro (tirzepatide) in India. Priced at Rs 14,000 for a 2.5 mg monthly dose (Rs ...

Novo Nordisk’s oral semaglutide tablet, Rybelsus, launched in India in January 2022, has already captured nearly 65 per cent of the anti-obesity drugs market, which includes other weight-loss ...

Diabetes management and weight-loss drug Mounjaro has been launched in India by makers Eli Lilly, following approval from the drug regulator. This has come amid rising cases of obesity and ...

The 48 innovative drugs cover nearly 20 therapeutic areas, including oncology, neurological disorders and anti-infective medicines, the report said. The number was the highest in the past five years, ...

The 48 innovative drugs cover nearly 20 therapeutic areas, including oncology, neurological disorders and anti-infective medicines, the report said. The number was the highest in the past five ...

Popular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a single-dose vial. Listen to Story Anti-diabetes and obesity drug Mounjaro ...